Zenosense’s (OTC: ZENO) MIDS Cardiac™ may prove
revolutionary in the niche cardiac diagnostic testing market, currently valued
between $2 and $6 billion in the U.S. A recent article discussing this, reads
“MIDS Cardiac™ is unique, because the technology is being developed to detect
very low levels of cardiac markers to deliver accuracy that’s equal or superior
to expensive state-of-the-art central laboratory analyzers, all while being
accessible at the point of care and offering results within minutes.”
To view the full article, visit http://ibn.fm/AYvAL
About Zenosense, Inc.
Zenosense Inc., through a joint-venture ownership in MIDS
Medical Ltd., is primarily focused on the development of a cost-effective,
hand-held Point of Care rapid cardiac diagnostic device, MIDS Cardiac. MIDS
Medical applies patent-protected magnetic nanoparticle detection technology and
a development team with world-class technical expertise. The MIDS Cardiac
device and test strip is being designed to support a variety of rapid high
sensitivity cardiac biomarker tests, with a focus on troponin I and T, to
identify or discount Acute Myocardial Infarction with accuracy equal or
superior to high sensitivity assays performed on laboratory analyzers. For more
information, visit the company’s website at www.Zenosense.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment